- Home
- BLDEW vs NTRS Comparison
BLDEW vs NTRS Comparison
Compare BLDEW & NTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLDEW
- NTRS
- Stock Information
- Founded
- BLDEW 2014
- NTRS 1889
- Country
- BLDEW United States
- NTRS United States
- Employees
- BLDEW 322
- NTRS N/A
- Industry
- BLDEW Transportation Services
- NTRS Major Banks
- Sector
- BLDEW Consumer Discretionary
- NTRS Finance
- Exchange
- BLDEW Nasdaq
- NTRS Nasdaq
- Market Cap
- BLDEW N/A
- NTRS N/A
- IPO Year
- BLDEW N/A
- NTRS N/A
- Fundamental
- Price
- BLDEW $0.23
- NTRS $130.03
- Analyst Decision
- BLDEW
- NTRS Hold
- Analyst Count
- BLDEW 0
- NTRS 13
- Target Price
- BLDEW N/A
- NTRS $115.08
- AVG Volume (30 Days)
- BLDEW 51.0K
- NTRS 1.9M
- Earning Date
- BLDEW 03-13-2025
- NTRS 07-23-2025
- Dividend Yield
- BLDEW N/A
- NTRS 2.33%
- EPS Growth
- BLDEW N/A
- NTRS 17.04
- EPS
- BLDEW N/A
- NTRS 8.52
- Revenue
- BLDEW $241,814,000.00
- NTRS $7,851,000,000.00
- Revenue This Year
- BLDEW N/A
- NTRS N/A
- Revenue Next Year
- BLDEW N/A
- NTRS $3.86
- P/E Ratio
- BLDEW N/A
- NTRS $15.12
- Revenue Growth
- BLDEW 12.04
- NTRS 3.17
- 52 Week Low
- BLDEW $0.30
- NTRS $80.81
- 52 Week High
- BLDEW $0.36
- NTRS $133.00
- Technical
- Relative Strength Index (RSI)
- BLDEW N/A
- NTRS 63.44
- Support Level
- BLDEW N/A
- NTRS $118.99
- Resistance Level
- BLDEW N/A
- NTRS $128.17
- Average True Range (ATR)
- BLDEW 0.00
- NTRS 2.93
- MACD
- BLDEW 0.00
- NTRS -0.53
- Stochastic Oscillator
- BLDEW 0.00
- NTRS 98.57
About BLDEW Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.